CytoDyn (CYDY) EPS (Diluted) (2020 - 2026)

CytoDyn (CYDY) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 CytoDyn 258.01 Mn 258.01 Mn - 0.00

Historic Data

Download Data
DateValue
Feb 28, 2026 0.00
Nov 30, 2025 -0.02
Aug 31, 2025 0.00
May 31, 2025 0.00
Feb 28, 2025 0.00
Nov 30, 2024 0.00
Aug 31, 2024 0.02
May 31, 2024 -0.02
Feb 29, 2024 -0.01
Nov 30, 2023 -0.01
Aug 31, 2023 -0.01
May 31, 2023 -0.02
Feb 28, 2023 -0.02
Nov 30, 2022 -0.03
Aug 31, 2022 -0.03
May 31, 2022 -0.12
Feb 28, 2022 -59.35
Nov 30, 2021 -0.06
Aug 31, 2021 -0.07
May 31, 2021 -0.12